Michael A. Linden

2.3k total citations
88 papers, 1.3k citations indexed

About

Michael A. Linden is a scholar working on Hematology, Molecular Biology and Oncology. According to data from OpenAlex, Michael A. Linden has authored 88 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Hematology, 26 papers in Molecular Biology and 25 papers in Oncology. Recurrent topics in Michael A. Linden's work include Multiple Myeloma Research and Treatments (22 papers), Lymphoma Diagnosis and Treatment (16 papers) and Acute Myeloid Leukemia Research (11 papers). Michael A. Linden is often cited by papers focused on Multiple Myeloma Research and Treatments (22 papers), Lymphoma Diagnosis and Treatment (16 papers) and Acute Myeloid Leukemia Research (11 papers). Michael A. Linden collaborates with scholars based in United States, Canada and Hong Kong. Michael A. Linden's co-authors include Brian G. Van Ness, Robert W. McKenna, Siegfried Janz, Brian Van Ness, Liangping Peng, Wan Cheung Cheung, Joong Su Kim, Roberto D. Polakiewicz, Davis Seelig and E. J. Ehrhart and has published in prestigious journals such as Journal of Clinical Investigation, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Michael A. Linden

84 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael A. Linden United States 20 582 562 306 165 147 88 1.3k
Khalid Tobal United Kingdom 20 751 1.3× 634 1.1× 164 0.5× 138 0.8× 108 0.7× 40 1.3k
Rajive Kumar India 19 328 0.6× 351 0.6× 146 0.5× 163 1.0× 147 1.0× 96 973
Charlotte Guldborg Nyvold Denmark 18 529 0.9× 364 0.6× 167 0.5× 98 0.6× 132 0.9× 73 982
Sophia Yohe United States 18 305 0.5× 316 0.6× 320 1.0× 78 0.5× 237 1.6× 62 1.2k
Liran I. Shlush Israel 21 667 1.1× 706 1.3× 215 0.7× 183 1.1× 52 0.4× 53 1.6k
Mithun Vinod Shah United States 18 529 0.9× 461 0.8× 336 1.1× 368 2.2× 311 2.1× 154 1.6k
Rajan Dewar United States 13 180 0.3× 510 0.9× 346 1.1× 163 1.0× 118 0.8× 32 1.2k
Barbara Czepulkowski United Kingdom 19 789 1.4× 556 1.0× 241 0.8× 277 1.7× 226 1.5× 49 1.7k
Paolo Peterlongo Italy 13 198 0.3× 450 0.8× 231 0.8× 206 1.2× 207 1.4× 31 1.0k
Caroline M. Bateman Australia 12 412 0.7× 359 0.6× 302 1.0× 70 0.4× 67 0.5× 23 1.0k

Countries citing papers authored by Michael A. Linden

Since Specialization
Citations

This map shows the geographic impact of Michael A. Linden's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael A. Linden with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael A. Linden more than expected).

Fields of papers citing papers by Michael A. Linden

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael A. Linden. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael A. Linden. The network helps show where Michael A. Linden may publish in the future.

Co-authorship network of co-authors of Michael A. Linden

This figure shows the co-authorship network connecting the top 25 collaborators of Michael A. Linden. A scholar is included among the top collaborators of Michael A. Linden based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael A. Linden. Michael A. Linden is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Groves, Christopher J., Michael A. Linden, Ahmad Al‐Attar, et al.. (2025). Ad hoc antibody modification of a validated flow cytometric immunophenotyping panel—recommendations and safeguards for clinical laboratories. Cytometry Part B Clinical Cytometry. 110(1). 11–21.
2.
Reid, Brie M., C. Desjardins, Bharat Thyagarajan, Michael A. Linden, & Megan R. Gunnar. (2024). Early Life Stress Is Associated with Alterations in Lymphocyte Subsets Independent of Increased Inflammation in Adolescents. Biomolecules. 14(3). 262–262. 3 indexed citations
3.
Johnson, Amanda, et al.. (2024). Pediatric TAFRO syndrome: A multi‐institution case series illustrating clinical challenges and excellent outcomes. Pediatric Blood & Cancer. 71(10). e31234–e31234. 2 indexed citations
4.
5.
6.
Baughn, Linda B., Erik Jessen, Neeraj Sharma, et al.. (2023). Mass Cytometry reveals unique phenotypic patterns associated with subclonal diversity and outcomes in multiple myeloma. Blood Cancer Journal. 13(1). 84–84. 4 indexed citations
7.
Kim, Jong Hyuk, Kate Megquier, Rachael Thomas, et al.. (2021). Genomically Complex Human Angiosarcoma and Canine Hemangiosarcoma Establish Convergent Angiogenic Transcriptional Programs Driven by Novel Gene Fusions. Molecular Cancer Research. 19(5). 847–861. 16 indexed citations
8.
Grzywacz, Bartosz, et al.. (2021). Indolent B-Lineage Precursor Populations Identified by Flow Cytometry and Immunohistochemistry in Benign Lymph Nodes. American Journal of Clinical Pathology. 157(2). 202–211. 3 indexed citations
9.
Christakopoulos, Georgios E., Todd E. DeFor, John E. Wagner, et al.. (2021). Phase I Dose-Finding, Safety, and Tolerability Trial of Romiplostim to Improve Platelet Recovery After UCB Transplantation. Transplantation and Cellular Therapy. 27(6). 497.e1–497.e6. 6 indexed citations
10.
Ng, Valerie, David L. Jaye, Manila Gaddh, et al.. (2020). Clinician-ordered peripheral blood smears have low reimbursement and variable clinical value: a three-institution study, with suggestions for operational efficiency. Diagnostic Pathology. 15(1). 112–112. 10 indexed citations
11.
Yohe, Sophia, et al.. (2019). CD161 Is Expressed in a Subset of T-Cell Prolymphocytic Leukemia Cases and Is Useful for Disease Follow-up. American Journal of Clinical Pathology. 152(4). 471–478. 6 indexed citations
12.
Tschida, Barbara R., Nuri A. Temiz, Jesse D. Riordan, et al.. (2017). Sleeping Beauty Insertional Mutagenesis in Mice Identifies Drivers of Steatosis-Associated Hepatic Tumors. Cancer Research. 77(23). 6576–6588. 34 indexed citations
13.
Rashidi, Armin, Michael A. Linden, Todd E. DeFor, et al.. (2017). History of consolidation is prognostic in acute myeloid leukemia patients undergoing allogeneic hematopoietic cell transplantation in minimal residual disease‐negative first complete remission. American Journal of Hematology. 92(10). 1032–1036. 15 indexed citations
14.
Thomas, Sarah, et al.. (2016). Clonal Lymphoproliferations in a Patient With Common Variable Immunodeficiency. Laboratory Medicine. 47(4). 318–325. 2 indexed citations
15.
Stessman, Holly A.F., Linda B. Baughn, Aaron L. Sarver, et al.. (2013). Profiling Bortezomib Resistance Identifies Secondary Therapies in a Mouse Myeloma Model. Molecular Cancer Therapeutics. 12(6). 1140–1150. 62 indexed citations
16.
17.
Stessman, Holly A.F., et al.. (2013). Bortezomib Resistance Can Be Reversed by Induced Expression of Plasma Cell Maturation Markers in a Mouse In Vitro Model of Multiple Myeloma. PLoS ONE. 8(10). e77608–e77608. 15 indexed citations
18.
Linden, Michael A., Nicole Kirchhof, Cathy S. Carlson, & Brian G. Van Ness. (2011). Targeted overexpression of an activated N-ras gene results in B-cell and plasma cell lymphoproliferation and cooperates with c-myc to induce fatal B-cell neoplasia. Experimental Hematology. 40(3). 216–227. 3 indexed citations
19.
Cheung, Wan Cheung, Joong Su Kim, Michael A. Linden, et al.. (2004). Novel targeted deregulation of c-Myc cooperates with Bcl-XL to cause plasma cell neoplasms in mice. Journal of Clinical Investigation. 113(12). 1763–1773. 79 indexed citations
20.
Liu, Xiangdong, Michael A. Linden, & Brian Van Ness. (2000). Induced κ Receptor Editing Shows No Allelic Preference in a Mouse Pre-B Cell Line. The Journal of Immunology. 165(12). 7058–7063. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Khalid Tobal Breakdown of academic impact, for papers by Rajive Kumar Breakdown of academic impact, for papers by Charlotte Guldborg Nyvold Breakdown of academic impact, for papers by Sophia Yohe Breakdown of academic impact, for papers by Liran I. Shlush Breakdown of academic impact, for papers by Mithun Vinod Shah Breakdown of academic impact, for papers by Rajan Dewar Breakdown of academic impact, for papers by Barbara Czepulkowski Breakdown of academic impact, for papers by Paolo Peterlongo Breakdown of academic impact, for papers by Caroline M. Bateman
Rankless by CCL
2026